| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010311450 |
| P356 | DOI | 10.1038/80459 |
| P698 | PubMed publication ID | 11017143 |
| P5875 | ResearchGate publication ID | 12306886 |
| P2093 | author name string | Boshoff C | |
| Kellam P | |||
| Radkov SA | |||
| P2860 | cites work | Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus | Q24561400 |
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene | Q28281071 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Regulation of retinoblastoma protein functions by ectopic expression of human cyclins | Q29618320 | ||
| The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product | Q29618372 | ||
| Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product | Q29620421 | ||
| The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth | Q33292242 | ||
| Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease | Q33647676 | ||
| Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
| p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
| Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. | Q33890688 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes | Q35550275 | ||
| Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. | Q35809792 | ||
| Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product | Q37016112 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. | Q39882226 | ||
| Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. | Q40831461 | ||
| Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus | Q41050488 | ||
| Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus | Q41051439 | ||
| Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. | Q42612163 | ||
| Cyclin encoded by KS herpesvirus | Q42633290 | ||
| G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator | Q42833351 | ||
| Kaposi's sarcoma. Coupling herpesvirus to angiogenesis | Q42833358 | ||
| KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway | Q42834462 | ||
| Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein | Q45801875 | ||
| Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus | Q47675996 | ||
| pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. | Q54048106 | ||
| Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
| The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells | Q73184792 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | retinoblastoma | Q500695 |
| P304 | page(s) | 1121-1127 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | |
| P478 | volume | 6 |
| Q39756815 | A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin |
| Q27680409 | A Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA Proteins |
| Q33826818 | A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest |
| Q33265370 | A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences |
| Q34531461 | A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. |
| Q40106826 | A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia |
| Q34179693 | A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. |
| Q35123088 | Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen |
| Q26743368 | Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus |
| Q33843421 | Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). |
| Q22251046 | Aids-related malignancies |
| Q37415110 | Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor |
| Q36884039 | An essential role for γ-herpesvirus latency-associated nuclear antigen homolog in an acute lymphoproliferative disease of cattle |
| Q36098894 | Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance |
| Q28750291 | Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus |
| Q79897199 | Apoptotic effect of ganciclovir on primary effusion lymphoma cells infected with Kaposi's sarcoma-associated herpesvirus |
| Q39729318 | Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus |
| Q38388893 | At a crossroads: human DNA tumor viruses and the host DNA damage response. |
| Q28269301 | BET domain co-regulators in obesity, inflammation and cancer |
| Q34092739 | Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. |
| Q39675686 | Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores |
| Q36086302 | Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis |
| Q34291968 | Cancer processes in immunodeficient populations: an introduction |
| Q36643922 | Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma |
| Q35584575 | Castleman's disease: from basic mechanisms to molecular therapeutics |
| Q39365643 | Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus |
| Q26749612 | Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA |
| Q38218288 | Cell cycle regulation during viral infection |
| Q34340317 | Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q38475163 | Claudin-2 downregulation by KSHV infection is involved in the regulation of endothelial barrier function |
| Q33883910 | Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus |
| Q39294399 | Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis |
| Q30535717 | Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation |
| Q28533244 | Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence |
| Q33895240 | Conservation of complex nuclear localization signals utilizing classical and non-classical nuclear import pathways in LANA homologs of KSHV and RFHV |
| Q40338623 | Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C. |
| Q34303583 | Contribution of viral mimics of cellular genes to KSHV infection and disease. |
| Q38264454 | Current status of treatment for primary effusion lymphoma |
| Q33853499 | DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q40169138 | Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen |
| Q35941628 | Deregulation of the cell cycle by the Epstein-Barr virus |
| Q35785433 | Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding |
| Q36691938 | Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus |
| Q40163096 | Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence |
| Q41891421 | Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus |
| Q39744147 | Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas |
| Q33673921 | E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. |
| Q33261811 | EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors |
| Q78860218 | Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes |
| Q33772234 | Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus |
| Q90702448 | Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease |
| Q24535609 | Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase |
| Q40637962 | Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing |
| Q40135893 | Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways |
| Q40252446 | Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx |
| Q42665921 | Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies |
| Q57029061 | FUS Negatively Regulates Kaposi's Sarcoma-Associated Herpesvirus Gene Expression |
| Q41924146 | Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication |
| Q34348453 | Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. |
| Q36192668 | Functional genomics and the development of pathogenesis-targeted therapies for Kaposi's sarcoma |
| Q37865141 | Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients |
| Q37060535 | Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program |
| Q34554716 | Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes |
| Q30479353 | HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus |
| Q38346932 | HIV TAT basic peptide is not a high-affinity ligand for VEGF receptor 2. |
| Q34572946 | HIV-associated Kaposi sarcoma: pathogenic mechanisms |
| Q34597442 | HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease |
| Q33917901 | Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP). |
| Q89783184 | Herpesviral Latency-Common Themes |
| Q34383861 | Human DNA tumor viruses generate alternative reading frame proteins through repeat sequence recoding |
| Q47552231 | Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase |
| Q37831159 | Human Herpesvirus-8 Infection Associated with Kaposi Sarcoma, Multicentric Castleman's Disease, and Plasmablastic Microlymphoma in a Man with AIDS: A Case Report with Review of Pathophysiologic Processes |
| Q55239038 | Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers. |
| Q34614394 | Human tumor-associated viruses and new insights into the molecular mechanisms of cancer |
| Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
| Q34423461 | Human viruses and cancer. |
| Q27001095 | Hypoxia-inducible factor 1 and its role in viral carcinogenesis |
| Q39882833 | Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation |
| Q89621489 | Identification of AIDS-Associated Kaposi Sarcoma: A Functional Genomics Approach |
| Q24646461 | Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q21131610 | Identification of cellular genes targeted by KSHV-encoded microRNAs |
| Q37307209 | Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis |
| Q92340148 | In Vivo Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus |
| Q40589924 | Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells |
| Q39794624 | Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. |
| Q35702343 | Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid |
| Q27486093 | Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers |
| Q36296882 | Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism. |
| Q42407453 | Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension |
| Q39610285 | Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein |
| Q38107828 | Interplay between DNA tumor viruses and the host DNA damage response. |
| Q33221441 | Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells. |
| Q40267803 | Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro |
| Q37410861 | Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus |
| Q43764140 | Is KSHV lytic growth induced by a methylation-sensitive switch? |
| Q26766437 | KSHV Genome Replication and Maintenance |
| Q36591375 | KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor |
| Q34774797 | KSHV LANA--the master regulator of KSHV latency |
| Q41662283 | KSHV and the Role of Notch Receptor Dysregulation in Disease Progression |
| Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
| Q38418556 | KSHV downregulation of galectin-3 in Kaposi's sarcoma |
| Q37237030 | KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription |
| Q40286016 | KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity |
| Q38692823 | KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation |
| Q35079842 | KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways |
| Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
| Q35642220 | KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development. |
| Q34711929 | KSHV/HHV8-associated lymphomas. |
| Q34291982 | KSHV/HHV8-associated lymphoproliferations in the AIDS setting |
| Q27026000 | KSHV: pathways to tumorigenesis and persistent infection |
| Q36731435 | Kaposi sarcoma as a model of oncogenesis and cancer treatment. |
| Q28540116 | Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway |
| Q40046587 | Kaposi sarcoma herpesvirus pathogenesis. |
| Q35127940 | Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis |
| Q33748042 | Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter |
| Q34470355 | Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment. |
| Q37016504 | Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders |
| Q43813237 | Kaposi virus scores cancer coup |
| Q35691156 | Kaposi's Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency |
| Q34976840 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells |
| Q34997083 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells |
| Q47606321 | Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology |
| Q29394711 | Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin? |
| Q36487309 | Kaposi's sarcoma and its associated herpesvirus |
| Q34556281 | Kaposi's sarcoma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8). |
| Q44277985 | Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. |
| Q34186981 | Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation |
| Q36019173 | Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein |
| Q36911800 | Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. |
| Q37424480 | Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation |
| Q41846091 | Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation |
| Q35139294 | Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest |
| Q39860632 | Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway |
| Q42328529 | Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells |
| Q39665994 | Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency |
| Q39210824 | Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation. |
| Q33838228 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. |
| Q40128647 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing |
| Q35689577 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells |
| Q35665756 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors |
| Q24673761 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes |
| Q36023151 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions. |
| Q38305362 | Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays |
| Q36540187 | Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency |
| Q42049779 | Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions |
| Q33737793 | Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway |
| Q40607781 | Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1 |
| Q30482603 | Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation |
| Q33744019 | Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency |
| Q39320195 | Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats |
| Q40335991 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function |
| Q34194120 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency |
| Q24543014 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats |
| Q35192868 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65. |
| Q36154559 | Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects |
| Q82344523 | Kaposi’s sarcoma-associated herpesvirus-encoded LANA positively affects on ubiquitylation of p53 |
| Q24314650 | LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription |
| Q34128791 | Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication |
| Q33854704 | Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells |
| Q34553088 | Latency-associated nuclear antigen expression and human herpesvirus-8 polymerase chain reaction in the evaluation of Kaposi sarcoma and other vascular tumors in HIV-positive patients |
| Q39852047 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation |
| Q40682995 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. |
| Q24670086 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus |
| Q39992257 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. |
| Q91637326 | Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1 |
| Q44486355 | Learning old tricks from new viruses |
| Q36223625 | Linking KSHV to human cancer |
| Q40287215 | Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo |
| Q40578287 | Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover |
| Q35168476 | Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling |
| Q33482148 | Malignant catarrhal fever of cattle is associated with low abundance of IL-2 transcript and a predominantly latent profile of ovine herpesvirus 2 gene expression |
| Q35678361 | Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers |
| Q39602182 | Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus |
| Q35010647 | Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation |
| Q36550916 | Messenger RNA turnover and its regulation in herpesviral infection |
| Q38674284 | Metabolic reprogramming: a hallmark of viral oncogenesis. |
| Q34437977 | Mitotic chromosome-binding activity of latency-associated nuclear antigen 1 is required for DNA replication from terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus |
| Q47547495 | Modified cross-linking, ligation, and sequencing of hybrids (qCLASH) identifies KSHV microRNA targets in endothelial cells |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q34663095 | Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS |
| Q35138059 | Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus |
| Q35110891 | Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus |
| Q33560572 | Molecular biology of KSHV in relation to AIDS-associated oncogenesis |
| Q34013830 | Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication |
| Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
| Q38863770 | Multicentric Castleman disease: Where are we now? |
| Q81505199 | Multiplex PCR-based DNA array for simultaneous detection of three human herpesviruses, EVB, CMV and KSHV |
| Q34022999 | Murine gamma-herpesvirus immortalization of fetal liver-derived B cells requires both the viral cyclin D homolog and latency-associated nuclear antigen |
| Q37252928 | Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency. |
| Q40066566 | ORF73 LANA homologs of RRV and MneRV2 contain an extended RGG/RG-rich nuclear and nucleolar localization signal that interacts directly with importin β1 for non-classical nuclear import |
| Q40173321 | ORF73 of Herpesvirus Saimiri Strain C488 Tethers the Viral Genome to Metaphase Chromosomes and Binds to cis -Acting DNA Sequences in the Terminal Repeats |
| Q37511491 | ORF73 of herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor proteins p53 and pRb. |
| Q40094006 | ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication |
| Q35841060 | Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis |
| Q35110909 | Pathogenesis and manifestations of human herpesvirus-8-associated disorders |
| Q35174136 | Pathogenesis of Kaposi's sarcoma |
| Q34456086 | Phosphorylation of the chromatin binding domain of KSHV LANA |
| Q24299259 | Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA |
| Q39959766 | Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency |
| Q35755464 | Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins - SUMO and KSHV |
| Q55518093 | Primary effusion lymphoma: current perspectives. |
| Q39271443 | Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas |
| Q38010467 | Prognosis in primary effusion lymphoma is associated with the number of body cavities involved |
| Q40292424 | Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus |
| Q35774091 | Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen |
| Q33282107 | Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. |
| Q24538878 | Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes |
| Q41866484 | Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins |
| Q42693319 | RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells |
| Q34295807 | Reactivation and role of HHV-8 in Kaposi's sarcoma initiation |
| Q35080754 | Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA |
| Q64375144 | Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene |
| Q34292265 | Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q37590325 | Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus |
| Q35964857 | Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes. |
| Q41849965 | Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen |
| Q37085853 | Regulation of the retinoblastoma proteins by the human herpesviruses. |
| Q38144129 | Review of latent and lytic phase biomarkers in Kaposi's sarcoma |
| Q35192690 | Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q37157253 | Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence |
| Q55338587 | Role of Pattern Recognition Receptors in KSHV Infection. |
| Q36060662 | Role of infectious diseases in human carcinogenesis |
| Q90368251 | Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma |
| Q34071388 | Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication |
| Q40605206 | Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation. |
| Q33906970 | Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases |
| Q37164834 | TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors |
| Q51831648 | Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence. |
| Q61449826 | The Critical Role of Genome Maintenance Proteins in Immune Evasion During Gammaherpesvirus Latency |
| Q34355898 | The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32. |
| Q41932132 | The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. |
| Q36099076 | The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc |
| Q38725485 | The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency |
| Q26747452 | The Modulation of Apoptotic Pathways by Gammaherpesviruses |
| Q26767186 | The Role of Gammaherpesviruses in Cancer Pathogenesis |
| Q37989143 | The Ubiquitin System and Kaposi's Sarcoma-Associated Herpesvirus |
| Q37157234 | The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters |
| Q35140238 | The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence |
| Q33845947 | The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters |
| Q41860564 | The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains |
| Q34391203 | The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma |
| Q35104781 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta |
| Q40496132 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest |
| Q34355092 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells |
| Q40811288 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter |
| Q33834414 | The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation |
| Q37380228 | The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency |
| Q40199723 | The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner |
| Q26995410 | The modulation of apoptosis by oncogenic viruses |
| Q34605505 | The molecular pathology of Kaposi's sarcoma-associated herpesvirus |
| Q38248404 | The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma |
| Q41692241 | The seroprevalence of Kaposi's sarcoma associated herpes virus and human herpes virus-6 in pediatric patients with cancer and healthy children in a Turkish pediatric oncology center |
| Q35847738 | The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production |
| Q36086767 | The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA |
| Q24685892 | The viral etiology of AIDS-associated malignancies |
| Q35917368 | Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders |
| Q34349469 | Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice |
| Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |
| Q33841257 | Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). |
| Q39960021 | Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. |
| Q39683497 | Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication. |
| Q39612221 | Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. |
| Q33947132 | Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. |
| Q93108742 | Tumor-Associated Protein Profiles in Kaposi Sarcoma and Mimicking Vascular Tumors, and Their Pathological Implications |
| Q34764819 | Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma |
| Q37692599 | Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition |
| Q37681282 | Viral epigenomes in human tumorigenesis. |
| Q37301053 | Viral manipulation of DNA repair and cell cycle checkpoints |
| Q33301012 | Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis |
| Q38106958 | Virus-associated lymphomagenesis |
| Q34308884 | Viruses and apoptosis |
| Q30384388 | Viruses and human cancers: a long road of discovery of molecular paradigms. |
| Q37811898 | Why do viruses cause cancer? Highlights of the first century of human tumour virology |
| Q43919089 | p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma |
Search more.